<DOC>
	<DOCNO>NCT01949753</DOCNO>
	<brief_summary>Characterization influence pregnenolone vs. placebo subjective distress autonomic function cognitive-behavioral exposure therapy patient obsessive-compulsive disorder .</brief_summary>
	<brief_title>Influence Pregnenolone Exposure Therapy Obsessive-compulsive Disorder</brief_title>
	<detailed_description>Main out-come parameter : Inter-session habituation per SUD ( 100 mm VAS ) , Y-BOCS Secondary out-come parameter : HF/LF HRV , Salivary epinephrine</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<criteria>OCD accord DSMIV criterion . Acute suicidality psychotic disorder , bipolar disorder substance dependency organic brain disorder pregnancy lactation tuberculosis gastric/duodenal ulcer diabetes mellitus acute inflammation autoimmune disorder arterial hypertension therapy glucocorticoid ( 4 week ago )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Obsessive-compulsive disorder ( OCD )</keyword>
	<keyword>Exposure therapy</keyword>
	<keyword>Extinction learning</keyword>
	<keyword>Pregnenolone</keyword>
</DOC>